Proteome Sciences (LON:PRM) Trading Down 16.7% – What’s Next?

Shares of Proteome Sciences plc (LON:PRMGet Free Report) traded down 16.7% on Thursday . The stock traded as low as GBX 2.30 ($0.03) and last traded at GBX 2.30 ($0.03). 288,265 shares traded hands during mid-day trading, an increase of 81% from the average session volume of 159,581 shares. The stock had previously closed at GBX 2.76 ($0.04).

Proteome Sciences Stock Down 5.1 %

The company has a market capitalization of £7.73 million, a PE ratio of -262.00 and a beta of 0.07. The stock’s 50 day moving average is GBX 3.01 and its two-hundred day moving average is GBX 3.38.

About Proteome Sciences

(Get Free Report)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.

Read More

Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.